Vital Chemtech Valuation
Is VITAL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VITAL?
Other financial metrics that can be useful for relative valuation.
| What is VITAL's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | ₹2.35b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2x |
| Enterprise Value/EBITDA | 15.8x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does VITAL's PE Ratio compare to its peers?
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 16.5x | ||
540078 Mitsu Chem Plast | 26.9x | n/a | ₹2.1b |
509486 Caprihans India | 4.6x | n/a | ₹3.1b |
541778 Deep Polymers | 22.5x | n/a | ₹2.0b |
506528 Keltech Energies | 11.9x | n/a | ₹1.7b |
VITAL Vital Chemtech | 29.2x | n/a | ₹2.4b |
Price-To-Earnings vs Peers: VITAL is expensive based on its Price-To-Earnings Ratio (29.2x) compared to the peer average (16.5x).
Price to Earnings Ratio vs Industry
How does VITAL's PE Ratio compare vs other companies in the IN Chemicals Industry?
Price-To-Earnings vs Industry: VITAL is expensive based on its Price-To-Earnings Ratio (29.2x) compared to the Indian Chemicals industry average (26.9x).
Price to Earnings Ratio vs Fair Ratio
What is VITAL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 29.2x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate VITAL's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of VITAL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VITAL (₹98.2) is trading above our estimate of fair value (₹5.55)
Significantly Below Fair Value: VITAL is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.